Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1998
03/31/1998US5733911 Antitumor agents and anticarcinogenic agents
03/31/1998US5733910 Pyridazinedione compounds useful in the treating neurological disorders
03/31/1998US5733908 Useful in the treatment of parkinson's disease and schizophrenia
03/31/1998US5733907 Aids therapy
03/31/1998US5733904 Method for prevention and treatment of viral infectious diseases for viral suppression
03/31/1998US5733903 Treatment of neoplastic tissue by water-soluble texaphyrine metal complexes
03/31/1998US5733902 Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
03/31/1998US5733901 Administering to treat skin and respiratory system disorders, inflammatory disorders of the bowel, and allergic rhinitis/conjunctivitis
03/31/1998US5733899 Method for treating infection using steroid based pharmaceutical compositions
03/31/1998US5733897 Imidobisphosphoric acids, and use therefor
03/31/1998US5733896 Viricide for retrovirus
03/31/1998US5733894 Water soluble polysaccharide oncotic agent
03/31/1998US5733893 Binding of fibroblast growth factor to oligosaccharides
03/31/1998US5733889 Cardiovascular disorders and enzyme inhibitors
03/31/1998US5733888 Injectable composition
03/31/1998US5733887 Related to avermectins and milbemycins
03/31/1998US5733886 Compositions of clindamycin and benzoyl peroxide for acne treatment
03/31/1998US5733880 Anthracene derivatives for use as anticancer agents
03/31/1998US5733869 Systemically administering stroma-free hemoglobin to a patient experiencing ventricular fibrillation during cardiac pulmonary resuscitation, and defibrillation to effect return of spontaneous cirulation in the patient
03/31/1998US5733867 Cholecystokinins and gastrin antagonist
03/31/1998US5733781 Dna and human immunodefficiency virus inhibitors
03/31/1998US5733742 Polyclonal immunoglobulin fab fragments
03/31/1998US5733578 Directly compressible high load acetaminophen formulations
03/31/1998US5733565 Male contraceptive implant
03/31/1998US5733562 Injectable medical device and method of use
03/31/1998US5733559 Cosmetics
03/31/1998US5733558 Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same
03/31/1998US5733535 Topical compositions containing N-acetylcysteine and odor masking materials
03/31/1998US5733532 Sun protecting cosmetic compositions comprising derivatives of dibenzoylmethane, of benzophenone and of triazine
03/31/1998US5733524 Screening for neuroprotective agents by administering them with infarct-producing amine compounds, then comparing responses in treated and untreated animals
03/31/1998US5732717 Administering 4-chloro-5-(imidazoline-2-ylamino)-6-methoxy-2-methylpyrimidine
03/31/1998CA2116356C Antimuscarinic bronchodilators
03/30/1998CA2216763A1 N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug
03/30/1998CA2214441A1 Polymer/hydrogen peroxide complexes
03/27/1998CA2216479A1 Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia
03/27/1998CA2214922A1 Benzothiophene compounds, compositions, and methods
03/26/1998WO1998012557A1 Therapeutic agent with quantitative consumption marker and method of monitoring therapeutic agent consumption
03/26/1998WO1998012332A1 Compositions and methods for treating intracellular diseases
03/26/1998WO1998012313A1 Method for screening compounds regulating the expression of human-inducible nitric oxide synthase
03/26/1998WO1998012243A1 Polymerizable biodegradable polymers including carbonate or dioxanone linkages
03/26/1998WO1998012228A1 Polymers containing polysaccharides such as alginates or modified alginates
03/26/1998WO1998012220A2 Novel tumor proteins
03/26/1998WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998WO1998012204A1 Human b-cell translocation genes-2 and 3
03/26/1998WO1998012203A1 Acid-functionalized saccharides as polyvalent anti-infectives
03/26/1998WO1998012200A1 A crystalline substance of cefditoren pivoxyl and the production of the same
03/26/1998WO1998012199A1 Intermediates and process for preparing olanzapine
03/26/1998WO1998012198A1 Process for producing ecteinascidin compounds
03/26/1998WO1998012197A1 Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates
03/26/1998WO1998012196A1 Nodulisporic acid derivatives
03/26/1998WO1998012195A1 2-carbonylthiazole derivatives and use of the same
03/26/1998WO1998012194A1 Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient
03/26/1998WO1998012191A1 Industrial process for producing quinolone-carboxylic acid derivatives and intermediates for synthesis of the same
03/26/1998WO1998012190A2 Phenoxathiin derivatives as inhibitors of monoamine oxidase
03/26/1998WO1998012189A1 Method of producing polyphenol-containing compositions
03/26/1998WO1998012185A1 Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
03/26/1998WO1998012183A1 Imidazoles with serotonin receptor binding activity
03/26/1998WO1998012181A1 Substituted heterocycles as anti-tumor agents
03/26/1998WO1998012177A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
03/26/1998WO1998011923A1 Identification of agents that protect against inflammatory injury to neurons
03/26/1998WO1998011915A1 Strain selection of pneumococcal surface proteins
03/26/1998WO1998011911A1 Use of cytokines and cytotoxic substances in a new method to treat tumors
03/26/1998WO1998011906A1 Phospholipid drug derivatives
03/26/1998WO1998011903A1 Chitosan derivatives for treating malignant tumours
03/26/1998WO1998011902A1 Injectable formulations of avermectins and milbemycins
03/26/1998WO1998011901A1 Inositol polyphosphate derivatives and methods of using same
03/26/1998WO1998011899A1 Platelet function potentiator and method of curing platelet dysfunction
03/26/1998WO1998011898A1 Reducing toxic effects of carboplatin using dithioethers
03/26/1998WO1998011897A1 Combination therapy for treatment of psychoses
03/26/1998WO1998011896A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/26/1998WO1998011895A1 A method for the prevention of migraine
03/26/1998WO1998011894A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound
03/26/1998WO1998011893A1 Olanzapine dihydrate d
03/26/1998WO1998011892A1 Positive ampa receptor modulation to enhance brain neurotrophic factor expression
03/26/1998WO1998011890A1 Use of benzopyranols to treat neurological disorders
03/26/1998WO1998011889A1 Ultramicroemulsions from spontaneously dispersible concentrates with antitumor, antiviral, virucide and antiparasitically active esters of bioflavonoid compounds
03/26/1998WO1998011888A1 Method of treating urinary incontinence
03/26/1998WO1998011887A2 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
03/26/1998WO1998011886A1 Use of inhibitors of retinoic acid activity for wound healing
03/26/1998WO1998011885A1 Reflux inhibitors
03/26/1998WO1998011884A1 Use of sibutramine analogues to prevent the development of diabetes
03/26/1998WO1998011883A1 Use of hexahydrolupulones as antibacterial agents
03/26/1998WO1998011882A1 Pharmaceutical compositions and methods
03/26/1998WO1998011881A1 Pharmaceutical compositions containing amisulpride and their therapeutic applications
03/26/1998WO1998011876A1 Bioflavonol glycoside peroxy esters and their preparation for pharmacologically effective concentrations and ultramicroemulsions
03/26/1998WO1998011875A1 Method and composition for rewetting contact lenses and relieving eye dryness
03/26/1998WO1998011853A1 Composition and method for acceleration of wound and burn healing
03/26/1998WO1998011789A1 Flavonol containing food supplements
03/26/1998WO1998011780A1 Novel parasiticide combination
03/26/1998WO1998011778A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases
03/26/1998WO1998006409A3 Composition containing vitamin a and its use, in particular against skin diseases
03/26/1998WO1998006400A3 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
03/26/1998WO1998005338A3 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
03/26/1998WO1998001159A3 Composition for enhanced uptake of polar drugs from mucosal surfaces
03/26/1998WO1997048724A3 Human metabotropic glutamate receptor
03/26/1998WO1997046672A3 Antisense nucleic acids and hammerhead ribozymes
03/26/1998WO1997043272A3 Benzofurans and benzopyrans as chronobiological agents
03/26/1998WO1997040063A3 Pathogenic escherichia coli associated protein espa
03/26/1998WO1997035990A3 Histone deacetylases, and uses related thereto
03/26/1998DE19639303A1 Use of non-peptide bradykinin antagonist compounds
1 ... 6674 6675 6676 6677 6678 6679 6680 6681 6682 6683 6684 6685 6686 6687 6688 6689 6690 6691 6692 6693 6694 ... 7860